Skip to main content

Table 5 Quality of life score according to the Residence, Smoking, and Occupation in CC patients

From: Quality of life among cervical cancer patients following completion of chemoradiotherapy at Ocean Road Cancer Institute (ORCI) in Tanzania

QLQ Items

Residence

P

Smoking

P

Occupation

P

Rural

Urban

Smokers

Non-smokers

Employed

Not employed

n = 202

n = 121

n = 18

n = 305

n = 8

n = 315

QLQ-C30 Functional scales

Global Health Status/QOL

63.6 ± 16.7

65.8 ± 19.1

0.251

71.3 ± 19.6

64.0 ± 17.5

0.044

70.8 ± 16.1

64.3 ± 17.7

0.264

Physical Functioning

86.7 ± 13.9

84.2 ± 15.6

0.255

87.4 ± 13.1

85.7 ± 14.7

0.764

90.8 ± 15.9

85.6 ± 14.5

0.162

Role Functioning

90.5 ± 17.3

89.5 ± 20.2

0.887

85.2 ± 27.3

90.4 ± 17.7

0.645

93.8 ± 12.4

90.1 ± 18.5

0.678

Emotional Functioning

81.2 ± 21.2

78.8 ± 25.0

0.822

84.3 ± 19.4

80.1 ± 22.9

0.649

82.3 ± 26.5

80.3 ± 22.6

0.590

Cognitive Functioning

79.8 ± 24.5

84.2 ± 22.7

0.096

81.5 ± 18.0

81.4 ± 24.2

0.580

89.6 ± 15.3

81.2 ± 24.1

0.406

Social Functioning

76.8 ± 29.4

72.9 ± 32.0

0.338

91.7 ± 21.6

74.4 ± 30.6

0.011

79.2 ± 30.5

75.2 ± 30.4

0.668

QLQ-C30 Symptom scales

Fatigue

15.1 ± 17.9

18.0 ± 20.1

0.253

17.3 ± 25.1

16.1 ± 18.4

0.792

5.6 ± 10.3

16.4 ± 18.9

0.073

Nausea & Vomiting

5.1 ± 15.4

5.1 ± 14.9

0.984

8.3 ± 25.7

4.9 ± 14.4

0.762

2.1 ± 5.9

5.2 ± 15.3

0.790

Pain

18.5 ± 21.0

22.0 ± 25.7

0.488

23.1 ± 30.3

19.6 ± 22.4

0.935

8.3 ± 17.8

20.1 ± 23

0.086

Dyspnea

3.5 ± 13.9

5.0 ± 14.7

0.210

7.4 ± 24.4

3.8 ± 13.4

0.752

4.2 ± 11.8

4.0 ± 14.3

0.748

Insomnia

11.9 ± 24.0

14.6 ± 27.2

0.452

14.8 ± 28.5

12.8 ± 25.1

0.470

4.2 ± 11.8

13.1 ± 25.5

0.377

Appetite Loss

9.7 ± 22.0

7.6 ± 21.0

0.201

18.5 ± 38.3

8.4 ± 20.2

0.378

8.3 ± 15.4

8.9 ± 21.8

0.691

Constipation

19.8 ± 27.3

17.6 ± 27.9

0.338

14.8 ± 28.5

19.2 ± 27.5

0.445

8.3 ± 15.4

19.3 ± 27.7

0.324

Diarrhea

4.8 ± 17.7

2.2 ± 12.0

0.138

7.4 ± 24.4

3.6 ± 15.2

0.344

0

3.9 ± 16.0

0.440

Financial difficulties

65.7 ± 36.1

60.3 ± 37.3

0.282

51.9 ± 46.0

64.4 ± 35.9

0.181

50.0 ± 39.8

64.0 ± 36.5

0.295

QLQ-CX24 Symptom scales

Symptom Experience

14.3 ± 11.2

13.9 ± 12.0

0.394

10.3 ± 9.1

14.4 ± 11.6

0.445

11.7 ± 8.3

14.2 ± 11.6

0.652

Body Image

18.7 ± 25.2

21.2 ± 28.4

0.544

7.4 ± 15.2

20.4 ± 26.8

0.050

13.9 ± 20.4

19.8 ± 26.6

0.781

Sexual/

Vaginal Functioning

25.7 ± 19.2

33.1 ± 24.2

0.252

27.8 ± 12.7

29.6 ± 22.4

0.989

50 ± 14.4

28.6 ± 22

0.071

Lymphoedema

8.2 ± 17.3

7.2 ± 18.4

0.362

11.1 ± 22.9

7.6 ± 17.3

0.634

0

8 ± 17.8

0.164

Peripheral Neuropathy

21.9 ± 27.0

24.2 ± 31.7

0.988

22.2 ± 32.3

22.8 ± 28.7

0.711

25 ± 46.3

22.7 ± 28.4

0.515

Menopausal Symptoms

13.7 ± 26.9

23.1 ± 34.7

0.018

22.2 ± 37.9

17.0 ± 29.9

0.821

20.8 ± 30.5

17.2 ± 30.4

0.622

Sexual Worry

43.7 ± 43.4

48.8 ± 44.1

0.319

40.7 ± 45.1

45.9 ± 43.6

0.597

45.8 ± 43.4

45.6 ± 43.7

0.997

QLQ-CX24 Functional scales

Sexual Activity

6.7 ± 16.7

13.2 ± 21.7

0.002

7.4 ± 18.3

9.2 ± 19.1

0.628

20.8 ± 30.5

8.8 ± 18.6

0.184

Sexual Enjoyment

41.4 ± 26.4

45.9 ± 33.7

0.598

44.4 ± 19.2

43.8 ± 30.8

0.978

88.9 ± 19.2

41.8 ± 29.2

0.011

  1. Values are in mean score ± SD. Significance P < 0.005 by Mann Whitney U test and significant values are bolded